Literature DB >> 19663883

The negative inotropic action of canrenone is mediated by L-type calcium current blockade and reduced intracellular calcium transients.

A R Costa1, L B Torres, E Medei, R A Ricardo, J P França, S Smaili, J H M Nascimento, M E M Oshiro, J W M Bassani, A T Ferreira, P J F Tucci.   

Abstract

BACKGROUND AND
PURPOSE: Adding spironolactone to standard therapy in heart failure reduces morbidity and mortality, but the underlying mechanisms are not fully understood. We analysed the effect of canrenone, the major active metabolite of spironolactone, on myocardial contractility and intracellular calcium homeostasis. EXPERIMENTAL APPROACH: Left ventricular papillary muscles and cardiomyocytes were isolated from male Wistar rats. Contractility of papillary muscles was assessed with force transducers, Ca(2+) transients by fluorescence and Ca(2+) fluxes by electrophysiological techniques. KEY
RESULTS: Canrenone (300-600 micromol L(-1)) reduced developed tension, maximum rate of tension increase and maximum rate of tension decay of papillary muscles. In cardiomyocytes, canrenone (50 micromol L(-1)) reduced cell shortening and L-type Ca(2+) channel current, whereas steady-state activation and inactivation, and reactivation curves were unchanged. Canrenone also decreased the Ca(2+) content of the sarcoplasmic reticulum, intracellular Ca(2+) transient amplitude and intracellular diastolic Ca(2+) concentration. However, the time course of [Ca(2+)](i) decline during transients evoked by caffeine was not affected by canrenone. CONCLUSION AND IMPLICATIONS: Canrenone reduced L-type Ca(2+) channel current, amplitude of intracellular Ca(2+) transients and Ca(2+) content of sarcoplasmic reticulum in cardiomyocytes. These changes are likely to underlie the negative inotropic effect of canrenone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19663883      PMCID: PMC2757698          DOI: 10.1111/j.1476-5381.2009.00329.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Contribution of Ca(2+) transporters to relaxation in intact ventricular myocytes from developing rats.

Authors:  Rosana A Bassani; José W M Bassani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

2.  Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes.

Authors:  J P Bénitah; G Vassort
Journal:  Circ Res       Date:  1999 Dec 3-17       Impact factor: 17.367

3.  Effect of potassium canrenoate on cardiac functions and (Na + + K + )-activated ATPase.

Authors:  S I Baskin; T Akera; C R Puckett; S L Brody; T M Brody
Journal:  Proc Soc Exp Biol Med       Date:  1973-06

4.  Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.

Authors:  W Sadée; M Dagcioglu; R Schröder
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

5.  ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America.

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

6.  cGMP-mediated inhibition of cardiac L-type Ca(2+) current by a monoclonal antibody against the M(2) ACh receptor.

Authors:  J H Nascimento; L Sallé; J Hoebeke; J Argibay; N Peineau
Journal:  Am J Physiol Cell Physiol       Date:  2001-10       Impact factor: 4.249

7.  Effects of canrenone on aorta and right ventricle of the rat.

Authors:  G Cargnelli; L Trevisi; P Debetto; S Luciani; S Bova
Journal:  J Cardiovasc Pharmacol       Date:  2001-05       Impact factor: 3.105

8.  Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.

Authors:  Ricardo Caballero; Ignacio Moreno; Teresa González; Cristina Arias; Carmen Valenzuela; Eva Delpón; Juan Tamargo
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

9.  Osmolality- and Na+ -dependent effects of hyperosmotic NaCl solution on contractile activity and Ca2+ cycling in rat ventricular myocytes.

Authors:  Rafael A Ricardo; Rosana A Bassani; José W M Bassani
Journal:  Pflugers Arch       Date:  2007-08-07       Impact factor: 3.657

10.  Rapid effects of aldosterone and spironolactone in the isolated working rat heart.

Authors:  John C Barbato; Patrick J Mulrow; Joseph I Shapiro; Roberto Franco-Saenz
Journal:  Hypertension       Date:  2002-08       Impact factor: 10.190

View more
  1 in total

Review 1.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.